{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:44:44Z","timestamp":1793857484686,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.autrev.2022.103038","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:13:48Z","timestamp":1641298428000},"page":"103038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"21","author":[{"given":"S.","family":"Giambalvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Garaffoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Silvagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Furini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bortoluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103038_bb0005","first-page":"10","article-title":"Review One year in review 2020: systemic lupus erythematosus","author":"Signorini","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.berh.2004.01.002","article-title":"New insights into sexual functioning and fertility in rheumatic diseases","volume":"18","author":"\u00d8stensen","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1529-0131(199805)41:5<831::AID-ART9>3.0.CO;2-1","article-title":"Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy","volume":"41","author":"Mok","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103038_bb0020","series-title":"update of the EULAR Recommendations for the Management Of Systemic Lupus Erythematosus n.d.:10","author":"Fanouriakis","year":"2019"},{"key":"10.1016\/j.autrev.2022.103038_bb0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103038_bb0030","first-page":"436","article-title":"Ovarian function and disease activity in patients with systemic lupus erythematosus","volume":"26","author":"Shabanova","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/apm.2020.02.11","article-title":"Assessment of ovarian reserve by serum anti-M\u00fcllerian hormone in patients with systemic lupus erythematosus: a meta-analysis","volume":"9","author":"Luo","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.autrev.2022.103038_bb0040","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2022.103038_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.autrev.2022.103038_bb0050","unstructured":"Study Quality Assessment Tools, NHLBI, NIH n.d. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools (accessed December 12, 2020)."},{"key":"10.1016\/j.autrev.2022.103038_bb0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.autrev.2022.103038_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002922.pub4","article-title":"Immunosuppressive treatment for proliferative lupus nephritis","author":"Tunnicliffe","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2022.103038_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0897.1992.tb00780.x","article-title":"The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis","volume":"28","author":"Langevitz","year":"1992","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2022.103038_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0961203315598246","article-title":"Assessment of anti-M\u00fcllerian hormone levels in premenopausal patients with systemic lupus erythematosus","volume":"25","author":"Gasparin","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103038_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-021-05677-9","article-title":"Adrenal steroidogenesis and ovarian reserve in adult childhood-onset systemic lupus erytematosus patients","author":"Louren\u00e7o","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00296-007-0478-3","article-title":"Ovarian failure in SLE patients using pulse cyclophosphamide: Comparison of different regimes","volume":"28","author":"Appenzeller","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2022.103038_bb0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1191\/0961203305lu2178oa","article-title":"Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto\u2019s thyroiditis","volume":"14","author":"Cabral de Sousa","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103038_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000439","article-title":"Anti-M\u00fcllerian hormone in African-American women with systemic lupus erythematosus","volume":"7","author":"Angley","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2022.103038_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejr.2020.06.001","article-title":"Impact of cyclophosphamide on gonadotropins in menopausal systemic lupus erythematosus patients: relation to disease activity and damage","volume":"42","author":"Elbakry","year":"2020","journal-title":"Egypt Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0100","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10067-014-2686-z","article-title":"Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia","volume":"33","author":"Alarfaj","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120300678828596","article-title":"Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy","volume":"9","author":"Blumenfeld","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103038_bb0110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1053\/j.ajkd.2008.06.017","article-title":"Hormonal Strategies for Fertility Preservation in Patients Receiving Cyclophosphamide to Treat Glomerulonephritis: A Nonrandomized Trial and Review of the Literature","volume":"52","author":"Cigni","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103038_bb0115","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00296-009-1192-0","article-title":"A comparative study of pregnancy outcomes and menstrual irregularities in northern Indian patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"30","author":"Gupta","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2022.103038_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/03009742.2014.908237","article-title":"Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?","volume":"43","author":"de Araujo","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/08916934.2013.817560","article-title":"Efficacy and toxicity of treatments for nephritis in a series of consecutive lupus patients","volume":"46","author":"Bozzolo","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2022.103038_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/096120339500400205","article-title":"New York University\/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: Efficacy in steroid unresponsive lupus nephritis","volume":"4","author":"Belmont","year":"1995","journal-title":"LUPUS"},{"key":"10.1016\/j.autrev.2022.103038_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-020-02292-y","article-title":"Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study","volume":"22","author":"Sharma","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103038_bb0140","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.20338","article-title":"Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis","volume":"50","author":"Takada","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103038_bb0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/0961203315617539","article-title":"Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand","volume":"25","author":"Akawatcharangura","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103038_bb0150","first-page":"450","article-title":"Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study","volume":"38","author":"Ceccarelli","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12020-018-1783-1","article-title":"Anti-M\u00fcllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve","volume":"63","author":"Di Mario","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2022.103038_bb0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0961203317726378","article-title":"Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age","volume":"27","author":"Gao","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103038_bb0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone","volume":"20","author":"Lawrenz","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103038_bb0170","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/jwh.2013.4255","article-title":"Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy","volume":"22","author":"Ma","year":"2013","journal-title":"J Women\u2019s Health (Larchmt)"},{"key":"10.1016\/j.autrev.2022.103038_bb0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/09513590.2014.922949","article-title":"Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus","volume":"30","author":"Malheiro","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.autrev.2022.103038_bb0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/art.37719","article-title":"Anti-m\u00fcllerian hormone and ovarian reserve in systemic lupus erythematosus","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103038_bb0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/S0482-50042010000500004","article-title":"Menstrual disturbances in systemic lupus erythematosus patients using immunossuppressants","volume":"50","author":"Nonato","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0190","first-page":"28","article-title":"Ovarian insufficiency is major short-term toxicity in systemic lupus erythematosus patients treated with cyclophosphamide","volume":"64","author":"Singh","year":"2016","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.autrev.2022.103038_bb0195","first-page":"731","article-title":"Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus","volume":"34","author":"Singh","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339500400103","article-title":"Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus","volume":"4","author":"Wang","year":"1995","journal-title":"LUPUS"},{"key":"10.1016\/j.autrev.2022.103038_bb0205","first-page":"38","article-title":"Menstrual and gonadal function alterations in women with systemic lupus erythematosus","volume":"63","author":"Mandal","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.autrev.2022.103038_bb0210","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/09513590.2011.650752","article-title":"Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients","volume":"28","author":"Marder","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.autrev.2022.103038_bb0215","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.55.4.224","article-title":"Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide","volume":"55","author":"McDermott","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103038_bb0220","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1590\/S0100-879X2001001200008","article-title":"Risk factors for ovarian failure in patients with systemic lupus erythematosus","volume":"34","author":"Medeiros","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.autrev.2022.103038_bb0225","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2013-1235","article-title":"Study of anti-M\u00fcllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide","volume":"98","author":"Morel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103038_bb0230","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103038_bb0235","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/art.40079","article-title":"Brief report: the euro-lupus low-dose intravenous cyclophosphamide regimen does not impact the ovarian reserve, as measured by serum levels of Anti-M\u00fcllerian hormone","volume":"69","author":"Tamirou","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103038_bb0240","article-title":"Ovarian antibodies among SLE women with premature menopause after cyclophosphamide","author":"Tsaliki","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103038_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/aji.12249","article-title":"Evaluation of ovarian reserve tests in women with systemic lupus erythematosus","volume":"72","author":"Ulug","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2022.103038_bb0250","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2022.103038_bb0255","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/1756-185X.13318","article-title":"Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study","volume":"21","author":"Koga","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103038_bb0260","first-page":"83","article-title":"Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil","volume":"28","author":"Laskari","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0265","first-page":"163","article-title":"Gonadotropins pituitary secretion in systemic lupus erythematosus","volume":"2","author":"Lavalle","year":"1984","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103038_bb0270","first-page":"343","article-title":"Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study","volume":"22","author":"Orefice","year":"2020","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2022.103038_bb0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1191\/0961203302lu163oa","article-title":"Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations","volume":"11","author":"Pasoto","year":"2002","journal-title":"Lupus"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:23:31Z","timestamp":1761600211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1568997222000088"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103038","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103038"}}